Article

Validation of a transcriptome-based assay for classifying cancers of unknown primary origin

2022-05-09

Abstract excerpt

Cancers assume a variety of distinct histologies and may originate from a myriad of sites including solid organs, hematopoietic cells, and connective tissue. Clinical decision making based on consensus guidelines such as NCCN is often predicated on a specific histologic and anatomic diagnosis, supported by clinical features and pathologist interpretation of morphology and immunohistochemical (IHC) staining pattern...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3b5950d2-9c04-5ae2-831a-6ad38610252e
DOI: 10.1101/2022.05.06.22274683

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Validation of a transcriptome-based assay for classifying cancers of unknown primary originDOI 10.1101/2022.05.06.22274683Read

Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor typeSemantic proximity Read

Cancer of unknown primary.Semantic proximity Read

Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features.Semantic proximity Read

Whole genome sequencing improves tissue of origin diagnosis and treatment options for cancer of unknown primarySemantic proximity Read

RNA-Seq Accurately Identifies Cancer Biomarker Signatures to Distinguish Tissue of OriginSemantic proximity Read

A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primarySemantic proximity Read

Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation featuresSemantic proximity Read

DNA sequencing and gene-expression profiling assists in making a tissue of origin diagnosis in cancer of unknown primarySemantic proximity Read

CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligenceSemantic proximity Read

Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation featuresSemantic proximity Read

Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primarySemantic proximity Read

Real-world data analysis of patients with cancer of unknown primarySemantic proximity Read